Paracetamol + Phenylephrine hydrochloride + Ascorbic acid
This medicine should always be taken exactly as described in this patient leaflet or as directed by a doctor, pharmacist, or nurse.
Coldrex Junior C is a medicine with analgesic and antipyretic effects, which constricts the blood vessels of the nasal mucosa and reduces its congestion, thereby relieving nasal congestion. The medicine contains vitamin C.
Coldrex Junior C is used for the short-term, symptomatic treatment of flu or colds, accompanied by fever, chills, headache, sore throat, and runny nose (catarrh) in children aged 6 to 12 years.
If there is no improvement after 3 days or the patient feels worse, they should consult a doctor.
Overdose of paracetamol may lead to irreversible liver damage.
The risk of overdose is higher in patients with alcoholic liver disease without cirrhosis.
Patients with diagnosed liver or kidney dysfunction must consult a doctor before taking the medicinal product.
Taking the medicinal product with paracetamol further increases the risk of liver damage in patients with liver disease.
Read the leaflet before taking the medicine and follow the instructions it contains.
Consult a doctor before taking the medicinein case of:
During treatment with Coldrex Junior C, immediately inform a doctor if the patient experiences severe diseases, including severe kidney dysfunction or sepsis (when bacteria and their toxins are present in the blood, leading to organ damage) or malnutrition, chronic alcoholism, or when the patient is also taking flucloxacillin (an antibiotic).
In these situations, patients have been reported to develop a severe disease called metabolic acidosis (a blood and body fluid disorder), when they took paracetamol in regular doses for a longer period or when they took paracetamol with flucloxacillin.
Symptoms of metabolic acidosis may include: severe breathing difficulties, including rapid deep breathing, drowsiness, feeling sick (nausea) and vomiting.
Liver damage is possible in individuals who have ingested more than 10 g of paracetamol at once.
Consuming 5 g of paracetamol may lead to liver damage in patients with the following risk factors:
Chronic use of various types of painkillers for headache may worsen it.
If such a situation occurs or is suspected, consult a doctor and discontinue treatment.
Caution should be exercised in patients with asthma who are also taking acetylsalicylic acid, as minor bronchospasm has been observed with paracetamol use (cross-reaction).
Keep the medicine out of sight and reach of children.
Do not give the medicine to children under 6 years of age.
Tell your doctor or pharmacist about all medicines you are taking, have recently taken, or might take.
Consult a doctor when taking the following medicines:
Concomitant use of paracetamol and drugs that increase liver metabolism, such as certain sedatives or antiepileptic drugs (e.g., phenobarbital, phenytoin, carbamazepine, St. John's wort), and rifampicin may lead to liver damage even when taking recommended doses of paracetamol.
Salcylamide prolongs the elimination time of paracetamol.
Caffeine enhances the analgesic effect of paracetamol.
Taking paracetamol may cause false results in some laboratory tests (e.g., blood glucose measurement).
Phenylephrine may enhance the blood pressure-increasing effect of drugs that accelerate labor.
Ascorbic acid increases iron absorption and increases aluminum absorption from aluminum-containing antacids.
Do not drink alcohol while taking the medicine due to the increased risk of liver damage.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a baby, consult a doctor or pharmacist before taking this medicine.
This medicine should not be taken during pregnancy.
Administration of phenylephrine hydrochloride during pregnancy may cause congenital malformations and may also cause fetal hypoxia.
During breastfeeding, do not take the medicine without consulting a doctor.
Phenylephrine may pass into breast milk.
There is no data on the effect of Coldrex Junior C on fertility.
Coldrex Junior C may cause dizziness.
If dizziness occurs after taking the medicine, do not drive or operate machinery.
The medicine contains 1.9 g of sucroseand 3.325 g of glucose per dose.
Consider this in patients with diabetes.
If a patient has previously been diagnosed with intolerance to some sugars, they should consult a doctor before taking the medicine.
The medicine contains 56.5 mg of sodium(the main component of common salt) per sachet.
This corresponds to 3% of the maximum recommended daily intake of sodium in the diet for adults.
The medicine contains sulfites.It may rarely cause severe hypersensitivity reactions and bronchospasm.
Always take this medicine exactly as directed by a doctor or pharmacist.
One sachet, if necessary, after 4 hours, the dose can be repeated, up to 4 times a day.
Do not take more frequently than every 4 hours or more than 4 sachets per day.
Always use the lowest effective dose of the medicine.
Children and adolescents
Administration in children under 6 years of age is contraindicated.
Children under 6 years of age should not be given available over-the-counter medicines containing phenylephrine used to treat colds and coughs.
Elderly patients
Elderly patients, especially the weak or immobile, may require a reduced dose or reduced frequency of administration.
Kidney dysfunction
Patients with diagnosed kidney dysfunction must consult a doctor before taking the medicine.
In the case of paracetamol administration to patients with kidney failure, it is recommended to reduce the dose and increase the minimum interval between each administration to at least 6 hours.
Liver dysfunction
Patients with diagnosed liver dysfunction or Gilbert's syndrome before taking the medicine must consult a doctor.
Before administration, the powder should be dissolved in hot water.
Pour the contents of one sachet into a glass, add half a glass of hot water, mix well, and drink.
If necessary, add cold water or sweeten.
Do not take the medicine in children under 6 years of age.
Without consulting a doctor, do not take the medicine regularly for more than 3 days.
If symptoms persist for more than 3 days or worsen, or if other symptoms occur, discontinue treatment and consult a doctor.
If the symptoms of the disease persist, consult a doctor.
If you feel that the effect of the medicine is too strong or too weak, consult a doctor.
Do not exceed the recommended daily dose or the specified number of doses due to the risk of liver damage.
In case of taking more than 4 sachets of the medicine within 24 hours, immediately consult a doctor, even if no adverse reactions occur, due to the risk of delayed, irreversible liver damage.
Do not take a double dose to make up for a missed dose.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Coldrex Junior C may also cause the following side effects, the frequency of which is unknown (cannot be estimated from the available data):
If you experience any side effects, including any side effects not listed in this leaflet, tell your doctor, pharmacist, or nurse.
Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products, Medical Devices, and Biocidal Products: Al. Jerozolimskie 181 C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help gather more information on the safety of the medicine.
Keep the medicine out of sight and reach of children.
Do not take the medicine after the expiry date stated on the packaging (EXP).
The expiry date refers to the last day of the specified month.
Store in a temperature below 25°C.
Medicines should not be disposed of via wastewater or household waste.
Ask your pharmacist how to dispose of medicines that are no longer needed.
This will help protect the environment.
A carton box contains 5 or 10 sachets.
Perrigo Poland Sp. z o.o.
ul. Domaniewska 48
02-672 Warsaw
tel.: +48 (22) 852 55 51
Omega Pharma International NV
Venecoweg 26
Nazareth, 9810
Belgium
Perrigo Supply Chain International Designated Activity Company
The Sharp Building
Hogan Place
Dublin 2
Dublin, D02 TY74, Ireland
Detailed information about this medicine is available on the website of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products.
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.